Bimekizumab for the treatment of moderate to severe psoriasis: a real-world experience over 52 weeks from two Italian dermatology clinics

Authors

Institutions

Publication Details

Journal
Journal of Dermatological Treatment
Published
2025-02-10
DOI
https://doi.org/10.1080/09546634.2024.2432932
Citations
5
Primary Topic
Psoriasis: Treatment and Pathogenesis
Type
article
Field-Weighted Citation Impact
3.99
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Bimekizumab for the treatment of moderate to severe psoriasis: a real-world experience over 52 weeks from two Italian dermatology clinics

Caterina Lanna, L. Bianchi, Edoardo Mortato, Antonia Rivieccio et al.
5 citations
Journal of Dermatological Treatment
Psoriasis: Treatment and Pathogenesis
3.99
article

Bimekizumab for the treatment of moderate to severe psoriasis: a real-world experience over 52 weeks from two Italian dermatology clinics

Caterina Lanna, L. Bianchi, Edoardo Mortato, Antonia Rivieccio, S. Lambiase, Fabio Artosi, Ruslana Gaeta Shumak, Cristiana Borselli, F. Loconsole, Elena Campione, I. Compagnucci
article en
5 citations

Abstract

No abstract available for this paper.
Journal of Dermatological TreatmentVol. 36(1)
University of Rome Tor Vergata (IT), University of Bari Aldo Moro (IT)
Good health and well-being
Openalex Percentile: Top 7%
Psoriasis: Treatment and Pathogenesis
3.99
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.